Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tsuno Group is a prominent Japanese enterprise specializing in the advanced utilization of rice bran for the production of fine chemicals, functional foods, and pharmaceutical ingredients. Founded in 1947 and headquartered in Wakayama, the company is a global leader in extracting bioactive compounds such as ferulic acid, gamma-oryzanol, and inositol. These products serve as critical components in the pharmaceutical industry for treating conditions like hyperlipidemia and autonomic nervous system disorders, as well as in the cosmetic industry for their potent antioxidant properties. Tsuno Group operates through a vertically integrated model, encompassing research, development, and large-scale manufacturing with a focus on sustainable upcycling of agricultural byproducts. Their commitment to quality and innovation has made them a primary supplier for global healthcare and personal care brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tsuno Group.